CStone Pharmaceuticals (2616.HK)

HKD 2.9

(5.07%)

Total Liabilities Summary of CStone Pharmaceuticals

CStone Pharmaceuticals's latest annual total liabilities in 2023 was 1.2 Billion CNY , up 1.35% from previous year.
CStone Pharmaceuticals's latest quarterly total liabilities in 2024 Q1 was 1.06 Billion CNY , down -11.68% from previous quarter.
CStone Pharmaceuticals reported annual total liabilities of 1.18 Billion CNY in 2022, up 11.71% from previous year.
CStone Pharmaceuticals reported annual total liabilities of 1.06 Billion CNY in 2021, up 31.69% from previous year.
CStone Pharmaceuticals reported quarterly total liabilities of 1.06 Billion CNY for 2024 Q2, down 0.0% from previous quarter.
CStone Pharmaceuticals reported quarterly total liabilities of 1.05 Billion CNY for 2023 Q1, down -11.19% from previous quarter.

Annual Total Liabilities Chart of CStone Pharmaceuticals (2023 - 2016)

Historical Annual Total Liabilities of CStone Pharmaceuticals (2023 - 2016)

Year	Total Liabilities	Total Liabilities Growth
2023	1.2 Billion CNY	1.35%
2022	1.18 Billion CNY	11.71%
2021	1.06 Billion CNY	31.69%
2020	808.29 Million CNY	72.32%
2019	469.06 Million CNY	-58.0%
2018	1.11 Billion CNY	886.32%
2017	113.22 Million CNY	91.32%
2016	59.18 Million CNY	0.0%

Year	Total Liabilities	Total Liabilities Growth
2024 Q1	1.06 Billion CNY	-11.68%
2024 Q2	1.06 Billion CNY	0.0%
2023 Q1	1.05 Billion CNY	-11.19%
2023 Q3	1.2 Billion CNY	14.12%
2023 Q2	1.05 Billion CNY	0.0%
2023 FY	1.2 Billion CNY	1.35%
2023 Q4	1.2 Billion CNY	0.0%
2022 Q1	1.06 Billion CNY	-0.03%
2022 FY	1.18 Billion CNY	11.71%
2022 Q4	1.18 Billion CNY	0.0%
2022 Q3	1.18 Billion CNY	11.75%
2022 Q2	1.06 Billion CNY	0.0%
2021 Q4	1.06 Billion CNY	0.0%
2021 Q3	1.06 Billion CNY	90.64%
2021 FY	1.06 Billion CNY	31.69%
2021 Q1	558.34 Million CNY	-30.92%
2021 Q2	558.34 Million CNY	0.0%
2020 Q1	378.86 Million CNY	-19.23%
2020 Q3	808.29 Million CNY	113.35%
2020 Q2	378.86 Million CNY	0.0%
2020 FY	808.29 Million CNY	72.32%
2020 Q4	808.29 Million CNY	0.0%
2019 Q3	457.96 Million CNY	383.16%
2019 FY	469.06 Million CNY	-58.0%
2019 Q4	469.06 Million CNY	2.42%
2019 Q2	94.78 Million CNY	0.0%
2019 Q1	94.78 Million CNY	-91.51%
2018 Q4	1.11 Billion CNY	63.57%
2018 Q1	- CNY	-100.0%
2018 Q3	682.75 Million CNY	0.0%
2018 FY	1.11 Billion CNY	886.32%
2017 FY	113.22 Million CNY	91.32%
2017 Q4	113.22 Million CNY	0.0%
2016 FY	59.18 Million CNY	0.0%

Peer Total Liabilities Comparison of CStone Pharmaceuticals

Name	Total Liabilities	Total Liabilities Difference
Uni-Bio Science Group Limited	152.81 Million HKD	-688.63%
CK Life Sciences Int'l., (Holdings) Inc.	7.05 Billion HKD	82.925%